Airway Stent and Lung Stent Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032
The Global Airway Stent/Lung Stent Market Size accounted for USD 112.6 Million in 2022 and is projected to achieve a market size of USD 204.4 Million by 2032 growing at a CAGR of 6.3% from 2023 to 2032.
Airway Stent/Lung Stent Market Highlights
- Global airway stent/lung stent market revenue is expected to increase by USD 204.4 Million by 2032, with a 6.3% CAGR from 2023 to 2032
- North America region led with more than 39% of airway stent/lung stent market share in 2022
- Asia-Pacific airway stent/lung stent market growth will record a CAGR of around 7% from 2023 to 2032
- By type, the tracheobronchial stents sub-segment generated over 73% share in 2022
- By material, the silicone stents segment of the market is expected to grow at a CAGR of 6.9% from 2023 to 2032
- Increasing prevalence of respiratory disorders such as lung cancer, COPD, and asthma, drives the airway stent/lung stent market value
An airway stent, also known as a lung stent, is a medical device used to maintain the patency of the airways, including the trachea, bronchi, and bronchioles. It is a flexible, cylindrical-shaped tube that is inserted into the airway to keep it open and allow the passage of air. Airway stents are used in patients with various respiratory disorders such as tracheobronchial strictures, tumors, and stenosis caused by external compression or inflammation. They are also used in patients with chronic obstructive pulmonary disease (COPD), lung cancer, and other respiratory conditions.
The airway stent/lung stent market has been growing steadily over the years. The increasing prevalence of respiratory disorders and the rising demand for minimally invasive procedures are the major drivers of market growth. The aging population and the growing awareness of the benefits of early diagnosis and treatment of respiratory disorders are also contributing to the growth of the market. In addition, technological advancements in stent design and materials have led to the development of more effective and durable stents, further boosting the market growth. North America is the largest market for airway stents, followed by Europe and the Asia Pacific region.
Global Airway Stent/Lung Stent Market Trends
Market Drivers
- Increasing prevalence of respiratory disorders such as lung cancer, COPD, and asthma
- Growing demand for minimally invasive procedures
- Technological advancements in stent design and materials
- Rising healthcare expenditure and awareness
- Aging population and longer life expectancy
Market Restraints
- High cost of airway stent/lung stent procedures
- Complications associated with stent placement, such as migration and infection
Market Opportunities
- Increasing adoption of biodegradable stents
- Growing demand for customized stents
Airway Stent/Lung Stent Market Report Coverage
| Market | Airway Stent/Lung Stent Market |
| Airway Stent/Lung Stent Market Size 2022 | USD 112.6 Million |
| Airway Stent/Lung Stent Market Forecast 2032 | USD 204.4 Million |
| Airway Stent/Lung Stent Market CAGR During 2023 - 2032 | 6.3% |
| Airway Stent/Lung Stent Market Analysis Period | 2020 - 2032 |
| Airway Stent/Lung Stent Market Base Year | 2022 |
| Airway Stent/Lung Stent Market Forecast Data | 2023 - 2032 |
| Segments Covered | By Type, By Product, By Material, By End User, And By Geography |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Key Companies Profiled | Boston Scientific Corporation, Cook Medical, C. R. Bard, Inc. (BD), Micro-Tech (Nanjing) Co., Ltd., Taewoong Medical Co., Ltd., Merit Medical Systems, Inc., Novatech SA, EFER Endoscopy, M.I. Tech Co., Ltd., Teleflex Incorporated, ENDO-FLEX GmbH, and Applied Medical Resources Corporation. |
| Report Coverage |
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Covid-19 Analysis, Regulation Analysis |
Tracheobronchial stent also known as lung stent is basically a tube-shaped device that is placed/inserted into an airway. It is usually placed bronchoscopically and laryngoscopically to treat various kinds of chronic lung diseases.
Rapidly increasing senior inhabitants, escalating inclination for minimally invasive techniques, and high occurrences of tobacco smoking are the major factors driving the growth of lung stents market. However, stringent rules and regulations for the endorsement of lung stents and the availability of treatment substitutes for lung diseases are affecting the growth of airway stent lung market. Nonetheless, increasing prevalence of lung cancer or related diseases and other respiratory infections can boost the growth of this market in forecast period.
Airway Stent/Lung Stent Market Segmentation
The global airway stent/lung stent market segmentation is based on type, product, material, end user, and geography.
Airway Stent/Lung Stent Market By Type
- Tracheobronchial Stents
- Laryngeal Stents
According to the airway stent/lung stent industry analysis, the tracheobronchial stents segment accounted for the largest market share in 2022. Tracheobronchial stents are used in the treatment of a range of respiratory disorders, including lung cancer, tracheal stenosis, and tracheobronchial strictures. These stents are also used to provide palliative care to patients with advanced lung disease or tumors, to help them breathe more easily and improve their quality of life. The tracheobronchial stents segment growth is driven by the increasing prevalence of respiratory disorders and the growing demand for minimally invasive procedures. The aging population and the rising awareness of the benefits of early diagnosis and treatment of respiratory disorders are also contributing to the growth of the tracheobronchial stents segment.
Airway Stent/Lung Stent Market By Product
- Self-expandable Stents
- Balloon-expandable Stents
- Non-expandable Stents
In terms of products, the self-expandable stents segment is expected to witness significant growth in the coming years. These stents are made of a shape memory material such as Nitinol, which allows them to expand and contract without losing their shape or functionality. Self-expandable stents are increasingly used in the treatment of respiratory disorders such as lung cancer, tracheal stenosis, and tracheobronchial strictures. They are preferred over other types of stents as they are less invasive and offer better outcomes. The self-expandable stents segment is expected to grow significantly in the coming years. This growth is driven by the increasing demand for minimally invasive procedures and the development of more advanced self-expandable stent technologies.
Airway Stent/Lung Stent Market By Material
- Metal Stents
- Nitinol Stents
- Stainless Steel Stents
- Other Metal Stents
- Silicone Stents
- Hybrid Stents
According to the airway stent/lung stent market forecast, the metal stents segment is expected to witness significant growth in the coming years. These stents are used in the treatment of respiratory disorders such as lung cancer, tracheal stenosis, and tracheobronchial strictures. Metal stents are preferred over other types of stents as they offer better support and are associated with lower migration rates. However, metal stents are associated with a higher risk of complications such as granulation tissue formation and stent fracture. The metal stents segment is expected to grow moderately in the coming years. This growth is driven by the increasing prevalence of respiratory disorders and the growing demand for minimally invasive procedures.
Airway Stent/Lung Stent Market By End User
- Hospitals
- Ambulatory Surgical Center
- Others
Based on the end user, the hospital segment is expected to continue its growth trajectory in the coming years. The hospital segment is one of the major end-users of airway stents, as these stents are widely used in the treatment of respiratory disorders such as lung cancer, tracheal stenosis, and tracheobronchial strictures. Hospitals are preferred over other healthcare settings as they have the necessary infrastructure and expertise to perform complex procedures and handle patients with critical respiratory conditions. The increasing prevalence of respiratory disorders and the growing demand for minimally invasive procedures are expected to drive the growth of the hospital segment in the airway stent market.
Airway Stent/Lung Stent Market Regional Outlook
North America
- U.S.
- Canada
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- India
- Japan
- China
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
The Middle East & Africa
- South Africa
- GCC Countries
- Rest of the Middle East & Africa (ME&A)
Airway Stent/Lung Stent Market Regional Analysis
North America dominates the airway stent/lung stent market due to several factors. One of the key factors is the increasing prevalence of respiratory disorders such as lung cancer and chronic obstructive pulmonary disease (COPD) in the region. According to the American Lung Association, lung cancer is the leading cause of cancer deaths in both men and women in the United States. The high incidence of respiratory disorders in the region has led to an increase in demand for airway stents, driving the growth of the market. Another factor contributing to the dominance of North America in the airway stent/lung stent market is the presence of well-established healthcare infrastructure and the availability of advanced medical technologies. The region has a large number of hospitals and healthcare facilities equipped with the latest medical technologies, enabling the diagnosis and treatment of respiratory disorders using airway stents. Additionally, the high healthcare expenditure in the region has also contributed to the growth of the lung stent market.
Airway Stent/Lung Stent Market Player
Some of the top airway stent/lung stent market companies offered in the professional report include Boston Scientific Corporation, Cook Medical, C. R. Bard, Inc. (BD), Micro-Tech (Nanjing) Co., Ltd., Taewoong Medical Co., Ltd., Merit Medical Systems, Inc., Novatech SA, EFER Endoscopy, M.I. Tech Co., Ltd., Teleflex Incorporated, ENDO-FLEX GmbH, and Applied Medical Resources Corporation.
Frequently Asked Questions
What was the market size of the global airway stent/lung stent in 2022?
The market size of airway stent/lung stent was USD 112.6 Million in 2022.
What is the CAGR of the global airway stent/lung stent market from 2023 to 2032?
The CAGR of airway stent/lung stent is 6.3% during the analysis period of 2023 to 2032.
Which are the key players in the airway stent/lung stent market?
The key players operating in the global market are including Boston Scientific Corporation, Cook Medical, C. R. Bard, Inc. (BD), Micro-Tech (Nanjing) Co., Ltd., Taewoong Medical Co., Ltd., Merit Medical Systems, Inc., Novatech SA, EFER Endoscopy, M.I. Tech Co., Ltd., Teleflex Incorporated, ENDO-FLEX GmbH, and Applied Medical Resources Corporation.
Which region dominated the global airway stent/lung stent market share?
North America held the dominating position in airway stent/lung stent industry during the analysis period of 2023 to 2032.
Which region registered fastest CAGR from 2023 to 2032?
Asia-Pacific region exhibited fastest growing CAGR for market of airway stent/lung stent during the analysis period of 2023 to 2032.
What are the current trends and dynamics in the global airway stent/lung stent industry?
The current trends and dynamics in the airway stent/lung stent industry include increasing prevalence of respiratory disorders such as lung cancer, COPD, and asthma, growing demand for minimally invasive procedures, and technological advancements in stent design and materials.
Which Type held the maximum share in 2022?
The tracheobronchial stents type held the maximum share of the airway stent/lung stent industry.
Select Licence Type
Connect with our sales team
Why Acumen Research And Consulting
100%
Customer Satisfaction
24x7
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
